Does T3 stimulate mitochondrial biogenesis, oxygen use, and metabolic rate?

Triiodothyronine (T3) acts as a primary genomic and non-genomic regulator of cellular bioenergetics, serving as a principal driver of metabolic rate and mitochondrial function.

Impact on cellular energetics

• Upregulation of metabolic rate: T3 stimulates cellular respiration, oxygen consumption, and basal metabolic rate. In humans, short-term T3 administration increases skeletal muscle tricarboxylic acid (TCA) cycle flux by approximately 70%.
• Modulation of metabolic efficiency: T3 decreases mitochondrial efficiency to maintain homeostasis. It promotes proton leak and upregulates uncoupling proteins (such as UCP-1 in adipose tissue and UCP2/3 in skeletal muscle), which dissipates the proton-motive force as heat and prompts compensatory substrate oxidation.
• Consequences of low free T3: When free T3 levels are low, this stimulatory signaling is compromised. Deprived cells exhibit diminished mitochondrial density, reduced expression of cytochrome c, and decreased adenine nucleotide translocase (ANT) content, which impairs ATP/ADP exchange. This reduces ATP synthesis and limits the cellular reserve needed during physical or metabolic demand.

Mechanistic pathways

• PGC-1α activation: T3 binds to nuclear thyroid hormone receptors to directly increase the transcription and expression of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α).
• Mitochondrial biogenesis cascade: PGC-1α co-activates nuclear respiratory factors (NRF-1 and NRF-2) to upregulate mitochondrial transcription factor A (TFAM). TFAM then binds and compacts mitochondrial DNA (mtDNA), driving the transcription and replication necessary to build new mitochondria.
• Direct organelle stimulation: Beyond the nucleus, T3 binds to mitochondrial receptor isoforms like p43, directly stimulating organelle-specific protein synthesis and enhancing respiratory chain activity.

Bottom line

• Low free T3 directly impairs cellular energy production by disrupting the T3/PGC-1α/TFAM transcriptonal pathway, reducing mitochondrial biogenesis, and downregulating the oxidative phosphorylation machinery required for efficient ATP synthesis.